Celldex Therapeutics (CLDX) Fails to deliver data

Key failure to deliver metrics for Celldex Therapeutics:

• Last SEC data release: 2026-02-27
• Last 15 days FTD volume: NZ$1.52 M
• Last 3 months FTD volume: NZ$1.83 M
• Last 12 months FTD volume: NZ$11.81 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Celldex Therapeutics (CLDX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Celldex Therapeutics (CLDX) - since 2019

Celldex Therapeutics (CLDX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	NZ$45.02 M	NZ$0.12 B	🇺🇸 USA
Amgen AMGN	NZ$0.23 B	NZ$0.33 B	🇺🇸 USA
GSK plc GSK	NZ$28.21 M	NZ$0.27 B	🇬🇧 UK
Titan Pharmaceuticals TTNP	N/A	NZ$0.24 M	🇺🇸 USA
Seagen SGEN	N/A	NZ$3.02 M	🇺🇸 USA
Agenus AGEN	NZ$0.34 M	NZ$4.22 M	🇺🇸 USA
Emergent BioSolutions EBS	NZ$0.18 M	NZ$3.67 M	🇺🇸 USA